A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer
Clinical trial NCT05241613 · TERMINATED
Trial details
- NCT number
- NCT05241613
- Sponsor
- Accutar Biotechnology Inc
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-16
- Primary completion
- 2024-03-05
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.